APPLIED DNA SCIENCES INC (APDN) Stock Income Statement
NASDAQ:APDN - Nasdaq - US03815U5083 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.79M | 3.43M | 13.37M | 18.17M | 9.03M | |||
| Minority Interest Expense | 108.60K | 95.80K | 76.00K | 2.00K | -8.00K | |||
| Cost Of Goods | 2.25M | 2.41M | 7.83M | 13.12M | 4.10M | |||
| Gross Profit | 1.54M | 1.02M | 5.53M | 5.05M | 4.93M | |||
| Operating Expenses | 14.59M | 15.04M | 16.49M | 19.02M | 17.22M | |||
| Research and Development | 3.61M | 3.59M | 3.73M | 3.93M | 3.77M | |||
| Selling, General, and Administrative Expenses | 10.98M | 11.45M | 12.75M | 15.10M | 12.61M | |||
| Operating Income | -13.04M | -14.02M | -10.95M | -13.97M | -12.29M | |||
| Interest Income/Expense | 259.30K | 176.30K | 75.00K | 7.00K | 14.00K | |||
| Other Income/Expense | 5.32M | 6.76M | 855.00K | 5.69M | -244.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -1.76M | |||
| Income Before Taxes | -7.47M | -7.09M | -10.02M | -8.27M | -14.28M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -46.19M | -7.23M | -9.95M | -8.38M | -14.29M | |||
| EBITDA | -12.66M | -13.33M | -9.59M | -12.68M | -11.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -35.66 | -91.09 | -760.47 | -934.00 | -2.06K | |||
| Non GAAP EPS | -642.75 | -348.00 | -750.00 | -1.00K | -1.95K | |||
| Statistics | ||||||||
| Gross Profit Margin | 40.76% | 29.64% | 41.39% | 27.82% | 54.59% | |||
| Profit Margin | -1218.46% | -210.57% | -74.41% | -46.11% | -158.24% | |||
| Operating Profit Margin | -344.11% | -408.72% | -81.94% | -76.89% | -136.17% | |||
All data in USD